NOAC Dosing in Atrial Fibrillation and Renal Dysfunction: What Measure Are You Using?
[...]approval of all NOACs by regulatory bodies, endorsement by societal guidelines for routine clinical use, as well as cutoffs for drug dosing are based on eCrCl values. (1), however, used the estimated glomerular filtration rate (eGFR) calculated with the Chronic Kidney Disease Epidemiology Colla...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2017-11, Vol.70 (21), p.2733-2734 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!